data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
SPY
––%
QQQ
––%
BTC/USD
––%
DIA
––%
GLD
––%
TLT
––%
Celldex Therapeutics
(NASDAQ:CLDX)
$36.66
At close: Dec 1(Delayed 15-Minutes)
Get Real Time Here
$36.66
PreMarket: 4:00PM EDT
Day Range- - -52 Wk Range19.85 - 42.46Open / Close- / -Float / Outstanding40M / 47.1M
Vol / Avg.- / 441.7KMkt Cap1.7BP/E-50d Avg. Price32.47
Div / Yield-Payout Ratio-Total Float40MEPS-0.57

Celldex Therapeutics Stock (NASDAQ:CLDX), Quotes and News Summary

Celldex Therapeutics Stock (NASDAQ: CLDX) stock price, news, charts, stock research, profile.

Day Range- - -52 Wk Range19.85 - 42.46Open / Close- / -Float / Outstanding40M / 47.1M
Vol / Avg.- / 441.7KMkt Cap1.7BP/E-50d Avg. Price32.47
Div / Yield-Payout Ratio-Total Float40MEPS-0.57
Vandana Singh - Jul 5, 2022, 3:57PM
Vandana Singh - Jul 1, 2022, 10:11AM
Globe Newswire - Nov 10, 2022, 4:01PM
Globe Newswire - Nov 9, 2022, 4:01PM
Globe Newswire - Aug 8, 2022, 4:01PM
Globe Newswire - Jul 21, 2022, 8:00AM
Globe Newswire - Jun 30, 2022, 6:01PM
Globe Newswire - Jun 21, 2022, 8:00AM
Globe Newswire - Jun 16, 2022, 4:01PM
Globe Newswire - Jun 6, 2022, 4:05PM
Globe Newswire - May 19, 2022, 9:23AM
Globe Newswire - May 5, 2022, 4:01PM
Globe Newswire - Feb 28, 2022, 4:01PM
Globe Newswire - Feb 22, 2022, 4:01PM
PRNewswire - Feb 21, 2022, 12:00AM
Globe Newswire - Feb 10, 2022, 4:05PM
PRNewswire - Jan 3, 2022, 5:00AM
Globe Newswire - Dec 8, 2021, 8:01AM
InvestorsObserver - Nov 14, 2022, 1:31PM
TipRanks - Nov 13, 2022, 10:55PM
TipRanks - Nov 10, 2022, 6:30AM
InvestorsObserver - Aug 30, 2022, 3:03PM
InvestorsObserver - Aug 18, 2022, 12:47PM
TipRanks - Aug 9, 2022, 8:35AM
TipRanks - Aug 9, 2022, 6:30AM
Seeking Alpha - Jul 21, 2022, 1:45PM
TipRanks - Jul 21, 2022, 10:15AM
TipRanks - Jul 8, 2022, 9:26AM
TipRanks - Jul 8, 2022, 8:36AM
TipRanks - Jul 5, 2022, 8:15AM
TipRanks - Jul 3, 2022, 10:44PM
InvestorsObserver - Jul 1, 2022, 7:54AM
Seeking Alpha - Jul 1, 2022, 6:41AM
InvestorsObserver - Jun 24, 2022, 12:26PM
TipRanks - Jun 21, 2022, 10:05AM
InvestorsObserver - Jun 3, 2022, 12:15PM
InvestorsObserver - Jun 2, 2022, 2:37PM
InvestorsObserver - May 31, 2022, 1:30PM
InvestorsObserver - May 25, 2022, 4:10PM
InvestorsObserver - May 18, 2022, 11:22AM
InvestorPlace - May 11, 2022, 8:13AM
TipRanks - May 8, 2022, 11:10AM
InvestorsObserver - May 6, 2022, 1:10PM
TipRanks - May 6, 2022, 6:26AM
InvestorsObserver - Mar 24, 2022, 3:47PM
InvestorsObserver - Mar 22, 2022, 4:15PM
TipRanks - Mar 3, 2022, 5:07AM
TipRanks - Mar 1, 2022, 6:25AM
Seeking Alpha - Feb 28, 2022, 8:57PM
InvestorsObserver - Feb 23, 2022, 2:32PM
InvestorsObserver - Feb 17, 2022, 3:14PM
TalkMarkets - Feb 7, 2022, 9:44AM
InvestorsObserver - Feb 2, 2022, 12:51PM
Sector: Health Care.Industry: Biotechnology
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.
Read More

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV
Q3 2022Est.ActualSurprise
EPS-0.580-0.570 0.0100
REV407.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Celldex Therapeutics (CLDX) stock?

A

You can purchase shares of Celldex Therapeutics (NASDAQ: CLDX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Celldex Therapeutics's (CLDX) competitors?

Q

What is the target price for Celldex Therapeutics (CLDX) stock?

A

The latest price target for Celldex Therapeutics (NASDAQ: CLDX) was reported by Guggenheim on Friday, November 11, 2022. The analyst firm set a price target for 63.00 expecting CLDX to rise to within 12 months (a possible 71.85% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Celldex Therapeutics (CLDX)?

A

The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $36.66 last updated December 1, 2022, 9:00 PM UTC.

Q

Does Celldex Therapeutics (CLDX) pay a dividend?

A

There are no upcoming dividends for Celldex Therapeutics.

Q

When is Celldex Therapeutics (NASDAQ:CLDX) reporting earnings?

A

Celldex Therapeutics’s Q4 earnings are confirmed for Monday, February 27, 2023.

Q

Is Celldex Therapeutics (CLDX) going to split?

A

There is no upcoming split for Celldex Therapeutics.

Q

What sector and industry does Celldex Therapeutics (CLDX) operate in?

A

Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.